Kairos Reports
Menu

AstraZeneca profit jumps 23% on cancer drugs as it unveils major savings plan

Euronews's headline. Reported by Euronews.

File picture: Julia Maudlin from Lake Oswego, Oregon, USA via Wikimedia Commons, CC BY 2.0

What Euronews reported

AstraZeneca's net profit jumped 23% in the third quarter on booming sales of its cancer drugs, as the British drugmaker unveiled a programme to save $1.5 billion (€1.34bn) a year to invest back into developing new medicines.

The publisher's own words, quoted for review. Every outlet carrying the story is listed below with its link.

AstraZeneca profit jumps 23% on cancer drugs as it unveils major savings plan. AstraZeneca's net profit jumped 23% in the third quarter on booming sales of its cancer drugs, as the British drugmaker unveiled a programme to save $1.5 billion (€1.34bn) a year to invest back into developing new medicines. Covered by 1 publications. Euronews: AstraZeneca profit jumps 23% on cancer drugs as it unveils major savings plan.

Who is covering it

  1. Euronews France AstraZeneca profit jumps 23% on cancer drugs as it unveils major savings plan AstraZeneca's net profit jumped 23% in the third quarter on booming sales of its cancer drugs, as the British drugmaker unveiled a programme to save $1.5 billion (€1.34bn) a year to invest back into developing new medicines. 3 h ago · Tier 3

Headlines and excerpts are the publishers' own, shown under quotation for review and linked to the originals.

More from Health

File picture: Eurico Zimbres via Wikimedia Commons, CC BY-SA 2.5
Breaking Business · Companies

Tech Firms’ Debt-Protection Costs are Surging on Profit Concerns

Costs to protect the debt of numerous US technology heavyweights against default hit fresh record highs Friday, with disappointing quarterly reports from Intel Corp. and Amazon.com Inc. spurring fresh concerns on whether the massive debt binge financing the AI boom will pay off. Excerpt, Bloomberg Markets

Source Bloomberg Markets